A 2026 review in the American Journal of Sports Medicine emphasizes that despite popularity, "significant research regarding the safety and efficacy of these therapeutic methods is required before definitive recommendations can be made to patients." Only a single human case series exists for BPC-157 (for knee pain), with significant methodological flaws and no controls
Lanjewar D, Katariya R, Kale V et al (2025) Interplay of neuropeptide Y and autophagy in Alzheimers disease: therapeutic perspectives and mechanistic insights
We run comprehensive labs (not just basic hormone panels), review your medical history, and design protocols that account for medications youre already taking
Similarly, Action for M.E. in England and Wales aim to spread awareness and education around ME/CFS and raise funds to support these patients and their families
Just the case for buying carefully if youre going to buy at all
It means third-party testing, clear documentation, and certificate of analysis reports researchers can actually understand